TBR Nederland

General information

The pharmacist has dispensed Zeposia® (0,23mg+0,46mg en 0,92mg) to the patient. The health insurer will not reimburse the cost of this prescription in full. The manufacturer of this medicine has therefore instructed TBR Nederland to reimburse to the patient the Personal Contribution charged.

Dose	Zeposia® (0,23mg+0,46mg and 0,92mg)
Type	Capsule
Active ingredient	OZANIMOD

Reimbursement

Conditions

The Personal Contribution for Zeposia® (0,23mg+0,46mg and 0,92mg) charged to the patient by the health insurer, is eligible for full reimbursement from 1 December 2020 to a maximium of € 250,- per patient per year. Therefore, the patient can submit a claim with TBR Nederland.

For this medicine a Doctor's Statement is not required. The claim form can be downloaded here or below under 'Submit a claim by post'.

Who can submit a claim

Patients or their carer can submit a claim for the Personal Contribution amount they paid for Zeposia® (0,23mg+0,46mg and 0,92mg), either online or by post. Online will be the fastest option. Pharmacists cannot claim the Personal Contribution on behalf of patients for this medicine.

From when till when can you submit a claim

Claims can be submitted to TBR Nederland up to three months after receipt of the invoice of the health insurance company. For the Reimbursement Scheme of this medicine no closing date has been determined yet.